GlassScriptPhysician profile
Aimee M Probasco
NPI 1508085929
$270.31
in general payments reported to CMS, 2019-2025
14 companies · $51.39 in 2025
The $51.39 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $126 · 2020: $43.02 · 2021: $13.59 · 2022: $17.30 · 2024: $19.34 · 2025: $51.39.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $70.73.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $70.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $33.73 | 2024-2025 | Veozah |
| Abbvie INC. | $30.42 | 2019-2021 | |
| Novo Nordisk INC | $27.81 | 2019 | |
| Amgen INC. | $27.19 | 2020-2025 | Evenity |
| Exeltis, USA INC. | $22.10 | 2025 | Slynd |
| Bayer Healthcare Pharmaceuticals INC. | $17.58 | 2020 | |
| Boston Scientific Corporation | $17.30 | 2022 | |
| Amarin Pharma, INC. | $16.92 | 2019 | |
| Sanofi Pasteur INC. | $15.15 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $13.85 | 2019 | |
| Roche Diagnostics Corporation | $13.28 | 2019 | |
| Allergan, INC. | $13.15 | 2020 | |
| Eisai INC. | $11.76 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $10.07 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aimee Probasco listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.